Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Core Laboratories Inc. /DE/ Director's Dealing 2025

Apr 2, 2025

32685_dirs_2025-04-02_007d35c2-a16f-486e-a38c-2b5deb340a69.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Core Laboratories Inc. /DE/ (CLB)
CIK: 0001958086
Period of Report: 2025-04-01

Reporting Person: ANASTASIO CURT (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-04-01 Common Stock M 9317 Acquired 15736 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-04-01 Restricted Shares $0 A 8069 Acquired Common Stock (8069) Direct
2025-04-01 Restricted Shares $0 M 9317 Disposed Common Stock (9317) Direct

Footnotes

F1: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2026, subject to the terms of issuance.

F2: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2025.